AUSHON: ULTRASENSITIVE IMMUNOASSAYS

Aushon Cirascan

Ultrasensitive Immunoassays and Biomarker Detection Combined with Multiplexing

aushon-machineThe Aushon Cira™ immunoassay platform revolutionizes protein biomarker research by combining ELISA’s sensitivity and reproducibility with all the advantages of multiplexing. The Cira™ system can maintain the consistency of a singleplex ELISA while enhancing sample throughput, affordability and sensitivity.

Ciraplex® assays allow multiplexing of up to 12 analytes per well using Aushon’s proprietary microarray printing technology. The combination of astronomy-grade optics with sophisticated, onboard analysis software improve signal-to-noise ratios for dramatically enhanced dynamic range and reproducibility.

From a quality perspective, Aushon’s Ciraplex® assays boast a large menu of over 300 manufacturer-validated kits across 6 species and deliver extremely consistent intra- and inter-plate results. Successful assays have been completed on cell supernatant, serum, plasma, BAL, CSF, mucosal washes, cell lysate and tissue homogenates.

Applications

  • Immuno-oncology
  • Infectious Diseases
  • Biomarkers
  • Inflammatory Conditions

Benefits

  • Wide, extendable, dynamic range
  • Multiplexing capabilities facilitates conservation of sample
  • Sample inputs include a diverse list of sample types
  • Chemiluminescent detection for enhanced low-end discrimination
  • Ultrasensitive assay kits detect down to femtogram per milliliter (fg/mL) levels
  • Custom arrays can be configured from the current menu of available analytes
  • Custom assay development and validation support available for novel markers

Expertise

Contact us today with your biomarkers of interest and let ABL’s scientists build an Aushon-based solution that best fits your study needs.

ABL & AUSHON BIOSYSTEMS ANNOUNCE ADOPTION OF THE CIRA™ PLATFORM

Aushon BioSystems and ABL announced that ABL has adopted the Cira platform for multiplex and ultrasensitive biomarker analysis.

Read More +